Navigation Links
Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:1/30/2008

SAN DIEGO, Jan. 30 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced today that the company is scheduled to present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 5, 2008 at 9:20 a.m. Eastern Time (6:20 a.m. Pacific Time) at the Grand Hyatt Hotel in New York City. Dominic P. Behan, Ph.D., Arena's Senior Vice President and Chief Scientific Officer, is scheduled to provide an overview of the company, including its clinical development and discovery programs.

A live audio webcast of the presentation will be available under the investor relations section of Arena's website at http://www.arenapharm.com. A replay of the presentation will be available for 30 days following the event. Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, includes compounds being evaluated independently and with its partners, Merck & Co., Inc. and Ortho-McNeil Pharmaceutical, Inc.

Arena Pharmaceuticals(R) and Arena(R) are registered service marks of the company. "APD" is an abbreviation for
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
2. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
3. Arena Pharmaceuticals Announces Public Offering of Common Stock
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. MAP Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Amylin Pharmaceuticals Reports 2007 Financial Results
8. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
9. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
10. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
11. Bradley Pharmaceuticals Announces Filing of Definitive Proxy Statement for Special Meeting of Stockholders to Approve Merger With Nycomed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Please join us for ... on Sunday, September 20th at Oneida Shores Park in Brewerton, NY. , Doris ... ruptured brain aneurysm at the young age of 59. Her family and friends have ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful rollout of ... of Cath Lab Accreditation in an Academic Setting, and The Importance of PVI Accreditation. ... taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions ...
(Date:8/3/2015)... ... ... pace of the economic recovery since the 2008 has been subject to much debate, the ... last six years. Unemployment has dropped from a 2009 high of 10 percent to 5.9 ... 2014, the U.S. stock market is at an all time high, and interest rates at ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Web SEO Master offers the most affordable web ... same business problem - making the most out of their dollar. Every company that ... It is crucial for existence. But not only does a start up need to ...
(Date:8/3/2015)... , ... August 03, 2015 , ... Representatives with ... service on its website. , “Our ‘Ask a Nutritionist’ feature on our website is ... eat healthily,” said Liza Brisk, nutritionist and spokeswoman for Health Food Grocers. , Health ...
Breaking Medicine News(10 mins):Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 2Health News:4th Annual Doris A. Connor Memorial Event for Brain Aneurysm Awareness to be Held in Brewerton, NY with Proceeds Benefitting Renowned Brain Aneurysm Foundation 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 2Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 3Health News:Newport Board group, an Advisory Firm Serving the Middle Market, Cautions Businesses on How to Survive the Coming Recession 4Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 2Health News:Web SEO Master, a division of SH Web Design & SH Web Commerce, Inc. begins offering Web Design and SEO Services for Start Up Companies located in Indianapolis, Indiana 3Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 2Health News:Health Food Grocers Launches "Ask a Nutritionist" Service 3
... with prostate cancer can improve their outcomes if they walk ... diagnosis, according to a recent study in Cancer Research ... "It appears that men who walk briskly after ... disease," said lead researcher Erin Richman, Sc.D., a research associate ...
... NEW YORK (May 23, 2011) -- Patients with ... clinical research study comparing two medications -- quetiapine ... and lithium, the gold-standard mood stabilizer. NewYork-Presbyterian ... sites nationally -- and the only site in ...
... 24, 2011For every year a person is homeless, the odds of ... to a report by St. Michael,s Hospital and Street Health. ... the lack of a health card, often because it has been ... in the journal Open Medicine , www.openmedicine.ca/article/view/368/407 , is ...
... May 24, 2011 The latest episode in ... " Global Challenges/Chemistry Solutions ," focuses on new ... are infected with an antibiotic-resistant bacterium that,s become ... This "superbug" is called methicillin-resistant Staphylococcus aureus, or ...
... , TUESDAY, May 24 (HealthDay News) -- Exercising ... why residents of Minneapolis-St. Paul find their city is now ... Every year, the American College of Sports Medicine (ACSM) ranks ... States, using the American Fitness Index (AFI). Although kicking the ...
... that their incomes start to rise not decline ... place says a Queen,s University School of Medicine professor. ... toward a Canadian-style system is feeble," says Jacalyn Duffin, ... medicine. "Physicians, incomes grew more quickly than those of ...
Cached Medicine News:Health News:Brisk walking could improve prostate cancer outcomes 2Health News:New study aims to improve long-term treatment for patients with bipolar disorder 2Health News:No health card means no family doctor for many homeless people 2Health News:New American Chemical Society podcast: Fast test to diagnose MRSA infections 2Health News:Twin Cities Take Top Ranking for Healthy Living 2
(Date:8/3/2015)... Pa. , Aug. 3, 2015 ... specialty biotechnology company focused on developing aerosolized KL4 ... live teleconference and webcast at 8:30 a.m. Eastern Time ... management will discuss the 2015 second quarter financial ... company will issue a press release announcing the ...
(Date:8/3/2015)... 3, 2015 Your doctor has recommended surgery ... for the best possible outcome. Your orthopaedic foot and ... and now there,s a three-part online series ... the American Orthopaedic Foot & Ankle Society (AOFAS) ... avoid complications and heal as quickly as possible. ...
(Date:8/3/2015)... SAN FRANCISCO , Aug. 3, 2015  Sage ... generation of portable laboratory-quality cannabis potency measurement systems, announced ... PAC Bay Area Cruise Fundraiser. A limited number of ... the festivities and help a great cause while enjoying ... a scenic cruise around the San Francisco Bay at ...
Breaking Medicine Technology:Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2Patient Guide: How to Prepare for Surgery 2Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2
... 1, 2011 PTC Therapeutics, Inc. (PTC) today announced ... of ataluren, an investigational new drug, in adults with ... Respiratory Journal . The published three-month data showed that ... chloride channel activity, CF-related cough and positive trends in ...
... READING, England and BEDMINSTER, N.J., June 30, 2011 ... Inc., today announced that the U.S. Food and Drug ... the management of breakthrough pain in cancer patients 18 ... and who are tolerant to opioid therapy for their ...
Cached Medicine Technology:Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 2Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 3Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 4Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 5Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 2FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 3FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 4FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 5FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 6FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 8